Epredia

Executive Summary

Epredia is a global leader in precision cancer diagnostics, specializing in histology instruments, consumables, and digital pathology solutions. Founded in 2019 and headquartered in Portsmouth, NH, the company builds on an 85-year legacy to provide foundational tools that enhance accuracy and efficiency in pathology laboratories worldwide. Its comprehensive product portfolio includes slide stainers, tissue processors, and digital scanners, enabling precise and timely cancer diagnoses. As a private entity, Epredia maintains a strong presence in the diagnostics market, serving academic institutions, hospitals, and reference labs. The company's focus on innovation and quality positions it as a key partner in the fight against cancer, though its private nature limits public financial disclosure.

Upcoming Catalysts (preview)

• TBDLaunch of next-generation digital pathology scanner70% success
• TBDFDA 510(k) clearance for AI-assisted tissue analysis software50% success
• TBDStrategic partnership for companion diagnostics with major pharma60% success